A. Shimatsu, “OSILODROSTAT IS EFFECTIVE AND WELL- TOLERATED IN ASIAN AND NON-ASIAN PATIENTS WITH CUSHING’S DISEASE: RESULTS FROM LINC 3 (PHASE III STUDY)”, J ASEAN Fed Endocr Soc, vol. 37, no. 2, pp. 75–76, Oct. 2022.